echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Neurology: Adjuvant cenopamine treatment can significantly improve uncontrolled focal seizures of epilepsy

    Neurology: Adjuvant cenopamine treatment can significantly improve uncontrolled focal seizures of epilepsy

    • Last Update: 2021-04-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Although in the past 25 years, new anti-medsci.


    medsci.


    The study included 18-65-year-old adult patients with focal seizures who were randomized 1:1 (cenopamine: placebo) after an 8-week baseline period.


     

    220 patients were randomized; 113 patients received cenopamine and 109 patients received placebo; 90.


     

    Compared with placebo, the median percentage of seizures in the cenopamine treatment group was reduced (55.


    In summary, the results of this study show that adjuvant cenopamine 200 mg/d can significantly improve uncontrolled focal seizures and is well tolerated.


     

    Original source:

     

    Steve S Chung, et al.


    ncbi.
    nlm.
    nih.
    gov/32409485/" target="_blank" rel="noopener">Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.